Perspective Therapeutics (CATX) Gross Margin Growth (1y) (2011 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -67.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -54.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -265.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 62.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -65.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 610.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -359.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 58.00
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 966.00
Jun 30, 2023 -2,043.00
Mar 31, 2023 -2,291.00
Sep 30, 2022 -1,602.00
Jun 30, 2022 -1,270.00
Mar 31, 2022 -287.00
Dec 31, 2021 -615.00
Sep 30, 2021 -1,213.00
Jun 30, 2021 267.00
Mar 31, 2021 -685.00
Dec 31, 2020 -89.00
Sep 30, 2020 -113.00
Jun 30, 2020 131.00
Mar 31, 2020 1,355.00
Dec 31, 2019 1,018.00
Sep 30, 2019 1,984.00
Jun 30, 2019 1,805.00
Mar 31, 2019 697.00
Dec 31, 2018 561.00
Sep 30, 2018 1,166.00
Jun 30, 2018 -871.00
Mar 31, 2018 1,586.00
Dec 31, 2017 3,467.00
Sep 30, 2017 1,744.00
Jun 30, 2017 4,064.00
Mar 31, 2017 1,735.00
Dec 31, 2016 -262.00
Sep 30, 2016 -214.00
Jun 30, 2016 -1,957.00
Mar 31, 2016 74.00
Dec 31, 2015 609.00
Sep 30, 2015 1,184.00
Jun 30, 2015 2,963.00
Mar 31, 2015 28.00
Dec 31, 2014 -44.00
Sep 30, 2014 210.00
Jun 30, 2014 -2,588.00
Mar 31, 2014 -1,037.00
Dec 31, 2013 1,314.00
Sep 30, 2013 -543.00
Jun 30, 2013 -628.00
Mar 31, 2013 -65.00
Dec 31, 2012 -3,245.00
Sep 30, 2012 -740.00
Jun 30, 2012 -1,852.00
Mar 31, 2012 -983.00
Dec 31, 2011 591.00
Sep 30, 2011 -1,078.00